CNC · Centene Corporation
$66.42
+1.56% last session
End-of-day data · close of 2026-09-11
Market cap
$33B
Enterprise value
$22B
Trailing P/E
—
Forward P/E
12.5
Dividend yield
—
Beta
1.11
Avg volume
5M
Employees
61K
Daily Change %
1.56%
5 Days Change
-2.45%
10 Days Change
0.26%
30 Days Change
-2.49%
60 Days Change
-4.23%
Month to Day Change
0.26%
Year to Day Change
58.93%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — CNC
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-08-11
Latest call per bank · past 12 months
JP Morgan
Neutral$67.00
+2.4% vs priceBarclays
Overweight$80.00
+22.3% vs priceWells Fargo
Equal-Weight$69.00
+5.5% vs priceRBC Capital
Sector Perform$71.00
+8.6% vs priceBank of America
Buy$74.00
+13.1% vs priceMorgan Stanley
Equal-Weight$57.00
-12.8% vs priceUBS
Neutral$61.00
-6.7% vs priceDeutsche Bank
Buy$80.00
+22.3% vs priceJefferies
Hold$39.00
-40.4% vs priceGoldman Sachs
Sell$38.00
-41.9% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-11 | Argus Research | Upgrade | Hold → Buy | $0.00 → $80.00 |
| 2026-08-04 | JP Morgan | Maintains | Neutral | $60.00 → $67.00 |
| 2026-08-03 | Bernstein | Maintains | Outperform | $68.00 → $79.00 |
| 2026-07-29 | Barclays | Maintains | Overweight | $75.00 → $80.00 |
| 2026-07-29 | Baird | Maintains | Neutral | $46.00 → $66.00 |
| 2026-07-14 | TD Cowen | Maintains | Hold | $47.00 → $65.00 |
| 2026-07-14 | Truist Securities | Maintains | Buy | $71.00 → $78.00 |
| 2026-07-13 | Wells Fargo | Maintains | Equal-Weight | $56.00 → $69.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-09-11
- RSI (14): RSI is 53 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 1.4% above the 50-day MA ($65.49).
- Price vs 200-day MA: Trading 30.4% above the 200-day MA ($50.92).
- MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- MACD (12,26,9): MACD histogram is negative (-0.02) — short-term momentum is fading.
- 52-week range: Price is within 5% of the 52-week high ($68.72).
CNC Price Chart
Loading chart for CNC…
Fundamentals
About Centene Corporation
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
More in Healthcare Plans
UNH
UnitedHealth Group Incorporated
$340B 19.2% YTD
CVS
CVS Health Corporation
$121B 22.9% YTD
ELV
Elevance Health, Inc.
$91B 20.6% YTD
CI
The Cigna Group
$74B 3.8% YTD
HUM
Humana Inc.
$49B 57.6% YTD
MOH
Molina Healthcare Inc
$11B 15.4% YTD
OSCR
Oscar Health, Inc.
$10B 126.7% YTD
ALHC
Alignment Healthcare, Inc.
$3B -35.4% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.